(MedPage Today) — Use of lorazepam-based regimens reduced persistent restlessness and agitation associated with end-of-life delirium in cancer patients, a randomized study showed.
Among 72 patients in a palliative care setting, those who received…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116844
Author :
Publish date : 2025-08-05 20:27:00
Copyright for syndicated content belongs to the linked Source.
